Revolution Medicines (NASDAQ:RVMD) Stock Price Expected to Rise, Guggenheim Analyst Says
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price increased by Guggenheim from $82.00 to $87.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s target price would indicate a potential upside of 78.02% from the stock’s previous close. Several other equities research […]
More Stories
Pan American Silver (NYSE:PAAS) Downgraded to “Hold” Rating by StockNews.com
StockNews.com lowered shares of Pan American Silver (NYSE:PAAS – Free Report) (TSE:PAAS) from a buy rating to a hold rating...
Endeavor Group (NYSE:EDR) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Endeavor Group (NYSE:EDR – Free Report) in a research note published on Sunday. The...
StockNews.com Initiates Coverage on LiqTech International (NASDAQ:LIQT)
Investment analysts at StockNews.com started coverage on shares of LiqTech International (NASDAQ:LIQT – Get Free Report) in a research report...
Q3 EPS Estimates for OTCMKTS:ANCTF Decreased by Desjardins
Alimentation Couche-Tard Inc. (OTCMKTS:ANCTF – Free Report) – Investment analysts at Desjardins reduced their Q3 2025 EPS estimates for Alimentation...
Q1 EPS Estimates for MKS Instruments Lifted by Analyst
MKS Instruments, Inc. (NASDAQ:MKSI – Free Report) – Investment analysts at Zacks Research raised their Q1 2025 earnings per share...
B. Riley Brokers Reduce Earnings Estimates for Iris Energy
Iris Energy Limited (NASDAQ:IREN – Free Report) – Equities researchers at B. Riley decreased their Q2 2025 EPS estimates for...